TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹3,031 Cr | ₹1,866 Cr | ₹1,844 Cr | ₹1,944 Cr | ₹1,632 Cr |
What is the latest Sundry Debtors ratio of TORRENT PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹3,031 Cr |
| Mar2025 | ₹1,866 Cr |
| Mar2024 | ₹1,844 Cr |
| Mar2023 | ₹1,944 Cr |
| Mar2022 | ₹1,632 Cr |
How is Sundry Debtors of TORRENT PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,031 Cr | 62.39 | |
| Mar2025 | ₹1,866 Cr | 1.20 | |
| Mar2024 | ₹1,844 Cr | -5.12 | |
| Mar2023 | ₹1,944 Cr | 19.07 | |
| Mar2022 | ₹1,632 Cr | - | |
Compare Sundry Debtors of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹191,546.6 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| MANKIND PHARMA | ₹105,068.0 Cr | -0% | 0.3% | -2.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.7% |
13% |
46.5% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses